EGFR 14.42% 9.63% ERBB2 2.40% 0.53% ERBB3 10.58% 1.07% ERBB4 21.63% 22.46% MET 14.90% 3.21% PDGFRA 11.54% 9.63% FGFR1 20.19% 52.41% FGFR2 0.96% 26.74% FGFR3 0.96% 0.53% FGFR4 1.44% 0.53% KIT 12.02% 20.86% IGF1R 0.96% 5.35% JAK2 0.96% RET 5.29% 26.20% ROS1 34.62% 2.14% ALK 7.21% 2.67% FLT3 4.33% 5.35% NTRK1 19.23% 5.35% NTRK2 0.75% 6.25% 5.88% NTRK3 4.33% 3.21% CBL 13.46% 2.14% ABL1 1.44% 8.56% SOS1 11.54% NF1 3.37% 8.02% RASA1 28.85% PTPN11 5.29% 0.53% KRAS 10.58% 6.42% HRAS 0.96% NRAS 16.83% 0.53% RIT1 19.71% ARAF 5.77% BRAF 0.75% 7.69% 1.07% RAF1 6.73% MAP2K2 1.44% 1.07% MAPK1 0.96% RAC1 2.40% 3.21% Cell survivalTranslationProliferationRAS/RAF pathway Fusion SV Noncoding DNA-methylation Alteration frequencies Oncogene <1% >1% >5% >10% Tumor Suppressor <1% >1% >5% >10% Note: Click gene name to see detailed information.
Copyright © Department of Urology, Changhai Hospital & Center for Translational Medicine. All rights reserved.